Seres Therapeutics, Inc.
MCRB
$4.54
$0.061.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.58M | -19.91M | -15.34M | 8.20M | -19.86M |
| Total Depreciation and Amortization | 670.00K | 781.00K | 9.35M | 1.04M | 1.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.63M | 4.02M | -3.21M | 4.61M | 4.40M |
| Change in Net Operating Assets | -37.28M | -1.25M | -5.52M | -11.65M | 1.10M |
| Cash from Operations | -22.39M | -16.36M | -14.71M | 2.21M | -13.29M |
| Capital Expenditure | -- | -- | -29.00K | -8.00K | -181.00K |
| Sale of Property, Plant, and Equipment | 14.00K | -- | 210.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 14.00K | -- | 181.00K | -8.00K | -181.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.72M | 428.00K | 12.66M | 61.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.72M | 428.00K | 12.66M | 61.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.67M | -15.93M | -1.87M | 2.26M | -13.47M |